<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03951948</url>
  </required_header>
  <id_info>
    <org_study_id>2019-00563; ch19Saxer</org_study_id>
    <nct_id>NCT03951948</nct_id>
  </id_info>
  <brief_title>Optimys Femoral Stem for Total Hip Replacement</brief_title>
  <acronym>Optihip</acronym>
  <official_title>Optimys Femoral Stem for Total Hip Replacement - a Clinical and Radiologic Follow-up of Minimum One Year</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This retrospective observational study analyses the surgical performance, clinical and
      radiologic outcome as well as the rate of infections with a main focus on revision surgeries
      after primary implantation of the Optimys short stem femoral prosthesis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 16, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>rate of reoperations</measure>
    <time_frame>one year follow-up period after Optimys femoral stem surgery</time_frame>
    <description>rate of reoperations after primary implantation of the Optimys short stem prosthesis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>rate of cortical hypertrophy</measure>
    <time_frame>at one year follow-up after Optimys femoral stem surgery</time_frame>
    <description>rate of cortical hypertrophy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of fractures</measure>
    <time_frame>one year follow-up period after Optimys femoral stem surgery</time_frame>
    <description>rate of fractures after the implantation of short stem femoral implants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of infections</measure>
    <time_frame>one year follow-up period after Optimys femoral stem surgery</time_frame>
    <description>rate of infections after the implantation of short stem femoral implants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>anatomic alignment on anterior-posterior (ap) view in DegreeÂ°</measure>
    <time_frame>at one year follow-up after Optimys femoral stem surgery</time_frame>
    <description>radiologic outcome defined by preciseness of the anatomic alignment compared to the contralateral side</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>subsidence</measure>
    <time_frame>at one year follow-up after Optimys femoral stem surgery</time_frame>
    <description>radiologic outcome defined by rate of subsidence after the implantation of short stem femoral implants (mm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain at rest (yes/no)</measure>
    <time_frame>at one year follow-up after Optimys femoral stem surgery</time_frame>
    <description>clinical outcome defined by pain at rest (yes/no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain under stress (yes/no)</measure>
    <time_frame>at one year follow-up after Optimys femoral stem surgery</time_frame>
    <description>clinical outcome defined by pain under stress (yes/no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>use of analgetics (yes/no)</measure>
    <time_frame>at one year follow-up after Optimys femoral stem surgery</time_frame>
    <description>clinical outcome defined by use of analgetics (yes/no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>use of walking aids</measure>
    <time_frame>at one year follow-up after Optimys femoral stem surgery</time_frame>
    <description>clinical outcome defined by use of walking aids</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>extent of periarticular ossification (PAO) according to Brooker classification system</measure>
    <time_frame>at one year follow-up after Optimys femoral stem surgery</time_frame>
    <description>Brooker classification system divides severity of PAO into 4 types:
A: islands of bone within the soft tissues about the hip B: bone spurs originating from the pelvis or proximal end of the femur, leaving at least 1 cm between opposing bone surfaces C: bone spurs originating from the pelvis or proximal end of the femur, reducing the space between opposing bone surfaces to less than 1 cm D: bone ankylosis of the hip</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Short Stem Prosthesis</condition>
  <condition>Optimys Femoral Stem</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>retrospective analysis of surgical performance, clinical and radiologic outcome</intervention_name>
    <description>retrospective analysis of surgical performance, clinical and radiologic outcome</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients treated for a proximal femoral fracture at the University Hospital Basel between
        29.10.2013 (date of introduction of the Optimys femoral component at the university
        hospital Basel) and 29.10.2018.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients treated with an Optimys femoral component at the University Hospital Basel
             between 29.10.2013 and 29.10.2018

        Exclusion Criteria:

          -  Clinical follow up at another Institution

          -  Documented dissent in study participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Clauss, Dr. med</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Basel, Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin Clauss, PD Dr. med</last_name>
    <phone>+41 61 32 86 007</phone>
    <email>Martin.Clauss@usb.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Daniel Rikli, Prof. Dr. MD</last_name>
    <phone>+41 61 55 65 391</phone>
    <email>Daniel.Rikli@usb.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Orthopaedics and Trauma Surgery (DOTS).</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Clauss, PD Dr. med.</last_name>
      <phone>+41 61 32 86 007</phone>
      <email>Martin.Clauss@usb.ch</email>
    </contact>
    <contact_backup>
      <last_name>Ilona Ahlborn</last_name>
      <email>Ilona.Ahlborn@usb.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 6, 2019</study_first_submitted>
  <study_first_submitted_qc>May 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 16, 2019</study_first_posted>
  <last_update_submitted>June 23, 2020</last_update_submitted>
  <last_update_submitted_qc>June 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>total hip replacement</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

